High-dose psilocybin shows promise for depression treatment

Researchers compare the effectiveness and acceptability of oral monotherapy with psychedelics for the treatment of depressive symptoms.

Canada approves AstraZeneca-Merck’s prostate cancer therapy

The trial evaluated Lynparza along with abiraterone versus placebo with abiraterone in male mCRPC patients. Credit: Image Point Fr / Shutterstock.com. AstraZeneca and Merck (MSD)

July 14, 2023

‘Get in Dorks’: Stand Up for Science rallies spread to 32 U.S. cities

Since Donald Trump took office in January, researchers across the U.S. have been waiting for scientific leaders to forcefully speak out against the administration’s grant

March 6, 2025

STAT Morning Rounds: The health news you need to read today

Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here. Buongiorno, Nalis here! A question for

December 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.